European regulators to review GSK's asthma drug Nucala to treat COPD
The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
Hosted on MSN11mon
Respiratory allergies: Newly discovered molecule plays a major role in triggering inflammation
The inflammation ... is released by lung epithelium cells a few minutes after exposure to a mold-type allergen. It cooperates with another alarmin, interleukin-33, to alert the immune system.
Nature2y
Developing the first inhaled live biotherapeutic to treat multiple inflammatory lung diseases
The researchers looked at the inflammation profiles of chronic lung disease patients and characterized ... 9), C-reactive protein (CRP), and interleukin 1 beta (IL-1β), and increased anti ...
Nature1y
Immune modulation: IL-1, master mediator or initiator of inflammation
Interleukin-1 (IL-1 ... and induction of inflammatory mediators 1. Excessive production of IL-1β drives the recurrent episodes of fever and systemic inflammation in certain autoinflammatory ...
Pulmonology Advisor1d
School Inner-City Asthma Study Finds Radon Exposure Linked to Increased IL-5
The prospective, epidemiologic School Inner-City Asthma Study (SICAS) evaluated potential biomarkers of inflammation associated with radon exposure among children aged 4 to 13 years with persistent ...
Healio1mon
Q&A: Lung inflammation decreases with form of vitamin B3 in COPD
Potential benefits of nicotinamide riboside in COPD include lower lung inflammation and elevated ... Scheibye-Knudsen: Most clinical studies use 1 g to 3 g of nicotinamide riboside, which is ...
Medical Xpress16d
From inflammation to fibrosis: Research explores cellular changes as COVID-19 lung damage worsens
Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS ... such as an increased expression of interleukin genes—proteins that regulate the immune ...